Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

1.7K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.7K
Inflammation01:38

Inflammation

57.0K
Overview
57.0K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

529
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
529
Inflammatory Response01:28

Inflammatory Response

14.4K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
14.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relative increase of memory B-cell subsets under s.c. B-cell-depleting therapies in multiple sclerosis.

Frontiers in immunology·2026
Same author

Methods to estimate marine functional connectivity: A primer.

Ecological applications : a publication of the Ecological Society of America·2026
Same author

Exploratory crossover field study indicates efficacy and feasibility of light therapy glasses to mitigate fatigue in multiple sclerosis.

Scientific reports·2026
Same author

Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseases.

Therapeutic advances in neurological disorders·2025
Same author

A probiotic approach identifies a Treg-centred immunoregulation via modulation of gut microbiota metabolites in people with multiple sclerosis and healthy individuals.

EBioMedicine·2025
Same author

Dietary galactose exacerbates autoimmune neuroinflammation <i>via</i> advanced glycation end product-mediated neurodegeneration.

Frontiers in immunology·2024

Related Experiment Video

Updated: Nov 6, 2025

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.9K

Inflammation in multiple sclerosis.

Stefanie Haase1, Ralf A Linker2

  • 1Neuroimmunologie, Klinik und Poliklinik für Neurologie, Universitätsklinik Regensburg, Franz-Josef-Strauss Allee, Regensburg, 93053, Germany.

Therapeutic Advances in Neurological Disorders
|May 5, 2021
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis (MS) involves complex immune cell interactions. Current therapies aim to shift immune cells toward an anti-inflammatory state, highlighting the collaborative role of T cells, B cells, and myeloid cells in MS immunopathology.

Keywords:
B cellsT cellsimmune networkimmune regulationinflammationmyeloid cellsrelapsing-remitting multiple sclerosis

More Related Videos

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
08:05

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice

Published on: March 1, 2017

9.4K
Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

5.0K

Related Experiment Videos

Last Updated: Nov 6, 2025

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.9K
Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
08:05

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice

Published on: March 1, 2017

9.4K
Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

5.0K

Area of Science:

  • Neuroimmunology
  • Central Nervous System (CNS) Disorders
  • Inflammatory Diseases

Background:

  • Multiple sclerosis (MS) is a chronic CNS inflammatory disease characterized by demyelination and neuro-axonal damage.
  • The precise mechanisms driving MS pathogenesis, particularly inflammatory demyelination, are not fully understood.
  • While T cells were initially considered primary drivers, B cells and myeloid cells are now recognized as critical contributors.

Purpose of the Study:

  • To provide a conceptual overview of the roles of T cells, B cells, and myeloid cells in the immunopathology of relapsing-remitting MS.
  • To discuss the impact of current disease-modifying therapies (DMTs) on these immune cell phenotypes.
  • To explore the concept of immunological cooperation among different immune cell types in MS.

Main Methods:

  • Literature review and conceptual synthesis of existing research on MS immunopathology.
  • Analysis of the known functions and interactions of T cells, B cells, and myeloid cells in the context of MS.
  • Examination of the effects of current MS therapies on immune cell populations and functions.

Main Results:

  • MS immunopathology involves a complex interplay between T cells, B cells, and myeloid cells, rather than a single cell type.
  • Existing disease-modifying therapies exert beneficial effects through immunological cooperation, influencing multiple immune cell types.
  • Current therapeutic strategies aim to promote an anti-inflammatory immune cell phenotype, including regulatory T cells, regulatory B cells, and anti-inflammatory macrophages.

Conclusions:

  • Understanding the coordinated action of diverse immune cells is crucial for comprehending MS pathogenesis.
  • Disease-modifying therapies for MS impact a range of immune cells, supporting a shift towards immune regulation.
  • Future therapeutic approaches may benefit from targeting these complex immune cell interactions to enhance regulatory immune responses in MS.